Stuart Marcus
- Sonalasense Inc (no department on record)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
FY2026 NIH rank #33,105
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 16120059Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2025 through FY2026Career claims are limited to the years shown.
NIH Funding · FY2026
Linked Award Amount
$497.4K
Full award amounts, FY2026
Award Records
1
Records listing this PI
Award-Linked Rank
#33,105
By linked amount among FY2026 PIs
Earliest Year Loaded
2025
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2026 award records by amount
NIH award records listing Stuart Marcus as a PI. Multi-PI records show the full award amount for context.
- 5R44CA275508-03R44Contact PISonodynamic therapy using MRI-guided focused ultrasound in combination with 5-aminolevulinic acid to treat recurrent glioblastoma multiforme$497.4Kaward amount
Award organization
Organizations that administered FY2026 awards listing Stuart Marcus as a PI.
FY2026 award administered by Sonalasense Inc (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2025First NIH AwardSonalasense Inc
- 2025$500K Cumulative Funding
- 2026$1M Cumulative Funding